And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We hope to catch up on some naps and our reading, hang with our short people, and stroll with our official mascot. And what about you? With a long, holiday weekend on this side of the pond, you could take time to binge watch a favorite show or curl up with a good book. You could also make time for someone special. Or place bets on when the U.S. government will re-open for business. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you on Tuesday …

The Food and Drug Administration plans to furlough more people and suspend lower-priority tasks to preserve money for drug reviews, including for new treatments for depression, diabetes, and several types of cancer, The Washington Post says. With money for drug reviews rapidly diminishing as the government shutdown drags into its fourth week, FDA Commissioner Scott Gottlieb says that he plans to curtail “discretionary activities” and call for additional furloughs in areas in which workloads have been reduced due to the shutdown.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy